Results 131 to 140 of about 13,106 (183)

Genome Agnostic Reprogramming of Acute Myelocytic Leukemia Hallmarks by Targeting Non-Oncogene Addictions with Azacitidine Plus Pioglitazone and All-Trans Retinoic Acid. [PDF]

Int J Mol Sci
Harrer DC, Lüke F, Pukrop T, Reichle A, Heudobler D.   +4 more
europepmc   +1 more source

Does age matter? Optimizing AML treatment in older adults. [PDF]

Blood Adv
Lai C, Lin TL.
europepmc   +1 more source

The Prognostic Value of the CD8⁺PD-1⁺/CD4⁺PD-1⁺ (PERLS) Ratio for Leukemic Transformation in MDS. [PDF]

Hematol Rep
Panagiotidis P, Karavanis E, Neanidis K, Panteris E, Moysidou M.   +4 more
europepmc   +1 more source

Molecularly targeted therapy and immunotherapy in leukemias. [PDF]

J Hematol Oncol
Cousin E, Picard A, Oundjian M, Tardif N, Quemener A, Rio AG, Galibert MD, Gandemer V, Mazurier F.   +8 more
europepmc   +1 more source

Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia-A Pilot Study. [PDF]

Cancer Med
Ye L, Xie M, Xu G, Mei C, Hu C, Zhou X, Ren Y, Ma L, Yang C, Qian J, Jin J, Tong H.   +11 more
europepmc   +1 more source

TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. [PDF]

Front Oncol
Deshpande S, Li WF, Song J, Forsberg M, Cerchione C, Martinelli G, Konopleva M.   +6 more
europepmc   +1 more source

VEXAS Syndrome: A Newly Recognized Entity to Consider in Systemic Disease-Associated Interstitial Lung Disease. [PDF]

Open Respir Arch
Cabrera-Cesar E, Martin SS, Carrasco GM.
europepmc   +1 more source

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review. [PDF]

Front Oncol
Zhao Y, Huang Z, Xue L, Zhang L, Jia Y.
europepmc   +1 more source

Medulloblastoma response to mevalonate pathway inhibition is independent of p53 status. [PDF]

Biol Direct
Comer C, Edwards C, Caporali S, Lu Y, Butera A, Michod D, Gruber AJ, Amelio I, Niklison-Chirou MV.   +8 more
europepmc   +1 more source

Real-life multicenter experience of long-term treatment with venetoclax plus azacitidine for acute myeloid leukemia in China. [PDF]

Sci Rep
Chen X, Yan Q, Li C, Liu F, Guo S, Zhao J, Liang Y, Wang H, Li W, Yuan G.   +9 more
europepmc   +1 more source